CLEC-2L Inhibitors
CLEC-2L Inhibitors principally includes compounds that can act on cellular signaling pathways related to immune responses, cellular stress, and reactions to external stimuli. Given the protein's possible association with the innate immune response and other cellular signaling pathways, these chemicals can indirectly influence the function or activity of CLEC-2L. For instance, Rapamycin is an mTOR inhibitor, regulating cellular responses to various stimuli, providing a route through which CLEC-2L can be influenced. Compounds like U0126, SB203580, and SP600125 target the MAPK signaling cascade, known for its pivotal role in cell responses to external and internal cues.
NF-κB, a key regulator of immune responses in cells, is targeted by several of the mentioned compounds like BAY 11-7082, JSH-23, and PDTC. By inhibiting the NF-κB pathway, these chemicals can indirectly influence the function or expression of proteins associated with immune response regulation. Staurosporine's broad-spectrum kinase inhibition further extends the range of cellular processes that can be affected, allowing for a wider modulation of CLEC-2L's function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits CLEC-2L by targeting mTOR, which regulates cellular responses to stress and external stimuli. | ||||||
NFκB Activation Inhibitor II, JSH-23 | 749886-87-1 | sc-222061 sc-222061C sc-222061A sc-222061B | 5 mg 10 mg 50 mg 100 mg | $214.00 $257.00 $1775.00 $2003.00 | 34 | |
Acts as an inhibitor of NF-κB nuclear translocation, thereby preventing its downstream effects and inhibiting CLEC-2L activity. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Functions as an inhibitor of NF-κB activation, leading to suppression of the NF-κB pathway and inhibition of CLEC-2L function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Suppresses JNK activity, impacting stress-activated protein kinase pathways and inhibiting CLEC-2L signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Serves as a p38 MAPK inhibitor, disrupting cellular responses to external stimuli and inhibiting CLEC-2L function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K activity, disrupting cellular responses and inhibiting CLEC-2L function. | ||||||
Pyrrolidinedithiocarbamic acid ammonium salt | 5108-96-3 | sc-203224 sc-203224A | 5 g 25 g | $33.00 $64.00 | 11 | |
Functions as an inhibitor of NF-κB activation, interfering with the NF-κB pathway and inhibiting CLEC-2L activity. | ||||||
IKK 16 | 1186195-62-9 | sc-204009 sc-204009A | 10 mg 50 mg | $223.00 $942.00 | 2 | |
Inhibits IKK activity, modulating the NF-κB pathway and leading to inhibition of CLEC-2L function. | ||||||